Healthcare • Drug Manufacturers - Specialty & Generic
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if CABR is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
2 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 2
10 filers reported a long position in CABR for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| FRANKLIN RESOURCES INC | $44.6K | 36K | New |
| VANGUARD CAPITAL MANAGEMENT LLC | $32.4K | 26.2K | +51.6% |
| GEODE CAPITAL MANAGEMENT, LLC | $30.9K | 24.9K | -57.6% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $25.8K | 20.8K | New |
| XTX Topco Ltd | $22.9K | 18.5K | -11% |
| JANE STREET GROUP, LLC | $19.4K | 15.6K | -56.1% |
| LPL Financial LLC | $12.4K | 10K | New |
| UBS Group AG | $4.4K | 3.5K | New |
| Tower Research Capital LLC (TRC) | $3K | 2.5K | +414.4% |
| Caitong International Asset Management Co., Ltd | $1 | 1 | New |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.